Jacobs Solutions Inc. (NYSE:J), the bioengineering titan, has seen significant movements in their stock holdings.
Oppenheimer Asset Management Inc., Todd Asset Management LLC, Truist Financial Corp, Asset Management One Co. Ltd., and others have actively increased their shares in the firm. Despite some Shares being sold by firms such as
New York State Common Retirement Funds and
Bryn Mawr Capital Management LLC, other institutions, including
Washington Trust Co., QRG Capital Management Inc., and Allworth Financial LP, have also raised their stock holdings. Notably,
Legato Capital Management LLC has sold a notable portion of shares.
Further, fascinating developments show Jacobs Solutions making industry waves, with a
$1.5 billion stock buyback plan announced, and a scheduled
dividend increase to $0.32. Moreover, with several strategic actions such as a spin-off of its critical mission solutions, and boosted growth plans expanding into water, infrastructure, and life sciences markets, investor interest appears robust. However, challenges continue with the stock underperforming the Nasdaq and S&P 500. The firm's 2025 outlook sees an expected EPS ranging from $5.85-$6.20.
Jacobs Solutions Stocks News Analytics from Sat, 24 Aug 2024 07:00:00 GMT to Sat, 01 Mar 2025 09:57:16 GMT -
Rating 5
- Innovation 8
- Information 8
- Rumor -4
